pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 25·1 min read
save

Experts say measles death counts are muddled by 'with' vs 'of' debate

Sep 25, 2026·read at STAT ↗Neutral

Public health scientists note that Pennsylvania reported two measles‑related deaths in August, but the county coroner described one infant as having died "with" measles rather than "from" the disease, attributing the fatality to a ruptured spleen.

The Centers for Disease Control and Prevention initially left all four Pennsylvania deaths out of its national measles update, marking the deaths column with an asterisk. Later the agency added one of the cases to its data but still omitted the remaining three.

In her first interview as CDC director, Erica Schwartz was asked about the exclusion and referenced the earlier Covid discussion about "died with" versus "died of" infections, suggesting a similar framing challenge.

The authors argue that concentrating on the wording of cause‑of‑death distracts from the broader cascade of factors that lead to mortality, and they call for clearer communication about measles risks.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: The ‘died with’ vs. ‘died of’ measles discussion misses something very important”

read at STAT ↗
1,637 words · retrieved Sep 25
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Cardiology2Infectious Disease2Pulmonology2HepatologyHypertensionVaccine

related stories

  • 1d agoVistagen cuts workforce for second time in 2026BioSpace
  • 5d agoMerck looks ahead to ‘another year of investment’ as Keytruda cliff loomsBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 23Fierce Biotech Layoff Tracker 2026: Enlivex excises 60%; Eyepoint halves headcountFierce Biotech
  • Dec 22Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series AFierce Biotech